| Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group | |
| Wu Tao; Yang Yong; Zhu Su-Yu; Shi Mei; Su Hang; Wang Ying; He Xia; Xu Li-Ming; Yuan Zhi-Yong; Zhang Li-Ling | |
| 2018 | |
| 卷号 | 2期号:18页码:2369-2377 |
| ISSN号 | 2473-9537 |
| DOI | 10.1182/bloodadvances.2018021311 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6354263 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Wu Tao,Yang Yong,Zhu Su-Yu,et al. Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group[J],2018,2(18):2369-2377. |
| APA | Wu Tao.,Yang Yong.,Zhu Su-Yu.,Shi Mei.,Su Hang.,...&Li Ye-Xiong.(2018).Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.,2(18),2369-2377. |
| MLA | Wu Tao,et al."Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group".2.18(2018):2369-2377. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论